Sfoglia per Autore
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis
2020 Schettini, F.; Pascual, T.; Conte, B.; Chic, N.; Braso-Maristany, F.; Galvan, P.; Martinez, O.; Adamo, B.; Vidal, M.; Munoz, M.; Fernandez-Martinez, A.; Rognoni, C.; Griguolo, G.; Guarneri, V.; Conte, P. F.; Locci, M.; Brase, J. C.; Gonzalez-Farre, B.; Villagrasa, P.; De Placido, S.; Schiff, R.; Veeraraghavan, J.; Rimawi, M. F.; Osborne, C. K.; Pernas, S.; Perou, C. M.; Carey, L. A.; Prat, A.
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer
2020 Miglietta, F.; Dieci, M. V.; Tsvetkova, V.; Griguolo, G.; Vernaci, G.; Menichetti, A.; Faggioni, G.; Giarratano, T.; Mioranza, E.; Genovesi, E.; Cumerlato, E.; Bottosso, M.; Saibene, T.; Michieletto, S.; Lo Mele, M.; Conte, P.; Guarneri, V.
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy
2020 Dieci, M. V.; Tsvetkova, V.; Griguolo, G.; Miglietta, F.; Tasca, G.; Giorgi, C. A.; Cumerlato, E.; Massa, D.; Lo Mele, M.; Orvieto, E.; Guarneri, V.; Conte, P.
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study
2020 Giarratano, T.; Frezzini, S.; Zanocco, M.; Giorgi, C. A.; Mioranza, E.; Miglietta, F.; Griguolo, G.; Falci, C.; Faggioni, G.; Tasca, G.; Di Liso, E.; Vernaci, G.; Menichetti, A.; Mantiero, M.; Grosso, D.; Guarneri, V.; Dieci, M. V.
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model
2020 Carbognin, L.; Simbolo, M.; Calio, A.; Vicentini, C.; Delfino, P.; Sperduti, I.; Fassan, M.; Schettini, F.; Dieci, M. V.; Griguolo, G.; Pilotto, S.; Fiorio, E.; Arpino, G.; Guarneri, V.; De Placido, S.; Conte, P.; Manfrin, E.; Brunelli, M.; Scambia, G.; Scarpa, A.; Tortora, G.; Bria, E.
The tumor microenvironment of primitive and metastatic breast cancer: Implications for novel therapeutic strategies
2020 Zarrilli, G.; Businello, G.; Dieci, M. V.; Paccagnella, S.; Carraro, V.; Cappellesso, R.; Miglietta, F.; Griguolo, G.; Guarneri, V.; Mele, M. L.; Fassan, M.
Olaparib for advanced breast cancer
2020 Griguolo, G.; Dieci, M. V.; Miglietta, F.; Guarneri, V.; Conte, P.
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors
2020 Dieci, M. V.; Miglietta, F.; Griguolo, G.; Guarneri, V.
HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade
2020 Prat, Aleix; Pascual, Tomás; De Angelis, Carmine; Gutierrez, Carolina; Llombart-Cussac, Antonio; Wang, Tao; Cortés, Javier; Rexer, Brent; Paré, Laia; Forero, Andres; Wolff, Antonio C; Morales, Serafín; Adamo, Barbara; Brasó-Maristany, Fara; Vidal, Maria; Veeraraghavan, Jamunarani; Krop, Ian; Galván, Patricia; Pavlick, Anne C; Bermejo, Begoña; Izquierdo, Miguel; Rodrik-Outmezguine, Vanessa; Reis-Filho, Jorge S; Hilsenbeck, Susan G; Oliveira, Mafalda; Dieci, Maria Vittoria; Griguolo, Gaia; Fasani, Roberta; Nuciforo, Paolo; Parker, Joel S; Conte, Pierfranco; Schiff, Rachel; Guarneri, Valentina; Osborne, C Kent; Rimawi, Mothaffar F
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype
2020 Guarneri, Valentina; Dieci, Maria Vittoria; Bisagni, Giancarlo; Brandes, Alba A; Frassoldati, Antonio; Cavanna, Luigi; Musolino, Antonino; Giotta, Francesco; Rimanti, Anita; Garrone, Ornella; Bertone, Elena; Cagossi, Katia; Nanni, Oriana; Piacentini, Federico; Orvieto, Enrico; Griguolo, Gaia; Curtarello, Matteo; Urso, Loredana; Paré, Laia; Chic, Nuria; D'Amico, Roberto; Prat, Aleix; Conte, Pierfranco
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial
2019 Dieci, M. V.; Bisagni, G.; Brandes, A. A.; Frassoldati, A.; Cavanna, L.; Giotta, F.; Aieta, M.; Gebbia, V.; Musolino, A.; Garrone, O.; Donadio, M.; Rimanti, A.; Beano, A.; Zamagni, C.; Soto Parra, H.; Piacentini, F.; Danese, S.; Ferro, A.; Cagossi, K.; Sarti, S.; Gambaro, A. R.; Romito, S.; Bazan, V.; Amaducci, L.; Moretti, G.; Foschini, M. P.; Balduzzi, S.; Vicini, R.; D'Amico, R.; Griguolo, G.; Guarneri, V.; Conte, P. F.
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1–T3, N0–N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study
2019 Dieci, M. V.; Guarneri, V.; Zustovich, F.; Mion, M.; Morandi, P.; Bria, E.; Merlini, L.; Bullian, P.; Oliani, C.; Gori, S.; Giarratano, T.; Orvieto, E.; Griguolo, G.; Michieletto, S.; Saibene, T.; Del Bianco, P.; De Salvo, G. L.; Conte, P.
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer
2019 Griguolo, G.; Pascual, T.; Dieci, M. V.; Guarneri, V.; Prat, A.
Androgen receptor expression and association with distant disease-free survival in triple negative breast cancer: Analysis of 263 patients treated with standard therapy for stage I-III disease
2019 Dieci, M. V.; Tsvetkova, Vassilena; Griguolo, G.; Miglietta, F.; Mantiero, Mara; Tasca, G.; Cumerlato, E.; Giorgi, C. A.; Giarratano, T.; Faggioni, GIULIA MARTINA; Falci, C.; Vernaci, G.; Menichetti, A.; Mioranza, Eleonora; Liso, E. D.; Frezzini, Simona; Saibene, T.; Orvieto, E.; Guarneri, V.
Use of electronic administrative databases to measure quality indicators of breast cancer care: Experience of five regional oncology networks in Italy
2019 Guarneri, V.; Pronzato, P.; Bertetto, O.; Roila, F.; Amunni, G.; Bortolami, A.; Tognazzo, S.; Griguolo, G.; Pagano, E.; Stracci, F.; Bianconi, F.; Gemmi, F.; Bachini, L.; Ciccone, G.; Paoli, G.; Paleari, L.; Conte, P. F.
Cardiac Safety of Adjuvant Trastuzumab and Paclitaxel for HER2+ early breast cancer patients published in Abstract Book of the 21th National Congress of Italian Association of Medical Oncology (AIOM) 25-27 October, 2019 - Rome, Italy Abstracts
2019 Frezzini, S.; Giarratano, T.; Griguolo, G.; Piccin, L.; Mioranza, E.; Giorgi, C. A.; Menichetti, A.; Miglietta, F.; Genovesi, E.; Cumerlato, E.; Bottosso, M.; Angelini, S.; Vernaci, G.; Dieci, M. V.; Guarneri., V.
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
2019 Miglietta, F.; Griguolo, G.; Guarneri, V.; Dieci, M. V.
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2 weeks letrozole: results of the PerELISA neoadjuvant study
2019 Guarneri, V; Dieci, M V; Bisagni, G; Frassoldati, A; Bianchi, G V; De Salvo, G L; Orvieto, E; Urso, L; Pascual, T; Paré, L; Galván, P; Ambroggi, M; Giorgi, C A; Moretti, G; Griguolo, G; Vicini, R; Prat, A; Conte, P F
Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer Center
2019 Dieci, Maria Vittoria; Ghiotto, Cristina; Barbieri, Caterina; Griguolo, Gaia; Saccardi, Carlo; Gangemi, Michele; Pluchinotta, Alfonso; Di Liso, Elisabetta; Giorgi, Carlo Alberto; Giarratano, Tommaso; Tasca, Giulia; Vernaci, Grazia; Faggioni, Giovanni; Conte, Pierfranco; Guarneri, Valentina
BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis
2019 Vernaci, G.; Dieci, M. V.; Manfrin, Silvia; Mantiero, M.; Falci, C.; Faggioni, G.; Mioranza, E.; Menichetti, A.; Tasca, G.; Griguolo, G.; Miglietta, F.; Di Liso, E.; Saibene, T.; Michieletto, S.; Ghiotto, C.; Conte, P.; Guarneri, V.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile